Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Oh deer! Antibodies to SARS-CoV-2 detected in 40% of wild white-tailed deer in four U.S. states

Researchers conducting a serosurveillance study of a North American deer species have provided evidence of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among the animals across four U.S. states.

1 Aug 2021

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Researchers in the United States have conducted a study showing the difference in antibody evolution following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between people who have not previously been infected with the virus and those who have.

1 Aug 2021

Fighting SARS-CoV-2 with nanomedicine

Published in the Journal of Controlled Release, researchers from the German University in Cairo, and the University of Cologne, looked into nano-reformulation of repurposed antiviral and immune-modulating drugs for inhalation therapy against COVID-19. In addition, they focused on how nanomedicine could address the limitations of current therapeutics, enhancing the efficacy, specificity, and safety of such drugs.

1 Aug 2021

Risk of myocarditis from SARS-CoV-2 infection is higher in young males, a study finds

The study highlights that young males with COVID-19 are more susceptible to develop myocarditis than those who received mRNA-based COVID-19 vaccines.

1 Aug 2021

Finding potential microRNAs from humans and plants against SARS-CoV-2

A new study focuses on the identification of probable miRNA candidates from three medicinal plants.

1 Aug 2021

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Considering the antiviral activity of medicinal herbs, a new study published in the journal Current Pharmacology Reports focuses on the identification of potent phytochemicals from Himalayan herbs, namely, Rheum emodi, Thymus serpyllum, and Artemisia annua, for the treatment of COVID-19.

1 Aug 2021

BNT162b2 vaccine shows high efficacy at six months

The Pfizer/BioNTech vaccine appears to be highly effective in protecting against the SARS-CoV-2 infection, including its relatively resistant beta variant B.1.351.

30 Jul 2021

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

A new study reports that the Johnson and Johnson vaccine against COVID-19 shows enhanced efficacy when administered to individuals with pre-existing antibodies.

30 Jul 2021

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

A new study published on the bioRxiv preprint server has developed the first computational model, i.e., a signaling network model, that can predict effective repurposed drug combinations to treat different phases of COVID-19 disease. This study has focused on identifying drugs for the treatment of early- and late-stage severe disease.

30 Jul 2021

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

A new study published on the bioRxiv* preprint server used molecular phylogenetic analysis to study the evolutionary trait of the Lambda variant.

30 Jul 2021

SARS-CoV-2 interacts with sialic acid cell surface glycans

In a paper recently uploaded to the journal Frontiers in Chemistry by Li et al. (July 22nd, 2021) the interaction between the SARS-CoV-2 spike protein and N-acetylneuraminic acid (NANA), the most commonly found sialic acid in humans, is investigated, finding that the molecule may act as a secondary or supplementary receptor to the virus.

30 Jul 2021

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Nanocovax is a protein subunit vaccine that contains the full-length spike stabilized by the addition of two prolines

29 Jul 2021

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

The current study explored ACE2-RBD interactions with four VoCs including the Alpha, Beta, Gamma, and Delta variants.

29 Jul 2021

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Scientists from the UK and US have recently investigated immunological consequences of secondary Streptococcus pneumoniae (S. pneumoniae) infection in coronavirus disease 2019 (COVID-19) patients.

29 Jul 2021

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Researchers in the United States have provided important insights into the antigen-specific cellular response and evolving humoral (antibody) response to messenger RNA- (mRNA) based vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

29 Jul 2021

Is it possible to identify pre-symptomatic and asymptomatic COVID-19 clinically?

The COVID-19 pandemic has severely impacted morbidity and mortality in nursing home residents across the world. Earlier detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may help better mitigate the risk of viral transmission. As both pre-symptomatic and asymptomatic transmission is common in these outbreaks, screening for threshold temperatures of 38°C or higher could miss timely detection in most infected people.

29 Jul 2021

World's most sophisticated COVID-19 sequencing system

In response to the ongoing SARS-CoV-2 infections in the United Kingdom, the COVID-19 Genomics UK (COG-UK) consortium was formed to rapidly sequence SARS-CoV-2 genomes as part of a national-scale genomic surveillance strategy.

29 Jul 2021

99% of COVID-19 deaths in Italy occur among those not fully vaccinated

In a new report out of Italy, health officials reported that almost 99 percent of people who have died from COVID-19 since February 2021 were not fully vaccinated. The report released by the National Health Institute (ISS) showed that the few fully vaccinated people who died of COVID-19 were also older than those who died without complete COVID-19 vaccine doses.

29 Jul 2021

Prior SARS-CoV-2 infection enhances effectiveness of Pfizer-BioNTech vaccine

A study conducted by researchers in Qatar has found that Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine was more protective against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among individuals who had previously been infected with the virus than among those who had not.

29 Jul 2021

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

Researchers in the United States have demonstrated the efficient aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – in a hamster model.

29 Jul 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Oh deer! Antibodies to SARS-CoV-2 detected in 40% of wild white-tailed deer in four U.S. states

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Fighting SARS-CoV-2 with nanomedicine

Risk of myocarditis from SARS-CoV-2 infection is higher in young males, a study finds

Finding potential microRNAs from humans and plants against SARS-CoV-2

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

BNT162b2 vaccine shows high efficacy at six months

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

SARS-CoV-2 interacts with sialic acid cell surface glycans

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Is it possible to identify pre-symptomatic and asymptomatic COVID-19 clinically?

World's most sophisticated COVID-19 sequencing system

99% of COVID-19 deaths in Italy occur among those not fully vaccinated

Prior SARS-CoV-2 infection enhances effectiveness of Pfizer-BioNTech vaccine

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in